Abstract
We report a structure–affinity analysis of an important element in the pharmacophore model for the recognition of 5-HT4 receptor antagonists: the voluminous substituent attached to the basic nitrogen of the ligand. We have designed, synthesized and pharmacologically evaluated a series of benzimidazole derivatives I containing a common molecular skeleton formed by N-[(4-piperidyl)methyl]-6-chlorobenzimidazole-4-carboxamide and four different substituents (R = butyl, 2-[(methylsulfonyl)amino]ethyl, 5-[(phenylacetyl)amino]pentyl, and 5-[(benzylsulfonyl)amino]pentyl). These compounds possess binding affinities in the nM range (K i = 0.11–1.50 nM). Moreover, a ligand that contains a hydrogen atom attached to the basic nitrogen (R = H; K i=150 nM) is used as a control for structure–affinity relationships.
Similar content being viewed by others
References
Muller, G., Curr. Med. Chem., 7 (2000) 861.
Venter, J.C., Adams, M.D., Myers, E.W., Li, P.W., Mural, R.J. et al., Science, 291 (2001) 1304.
Lander, E.S., Linton, L.M., Birren, B., Nusbaum, C., Zody, M.C. et al., Nature, 409 (2001) 860.
Spiegel, A.M., Annu. Rev. Physiol., 58 (1996) 143.
Palczewski, K., Kumasaka, T., Hori, T., Behnke, C.A., Motoshima, H., Fox, B.A., Trong, I.L., Teller, D.C., Okada, T., Stenkamp, R.E., Yamamoto, M. and Miyano, M., Science, 289 (2000) 739.
Horn, F., Weare, J., Beukers, M.W., Hörsch, S., Bairoch, A., Chen, W., Edvardsen, Ø., Campagne, F. and Vriend, G., Nucleic Acids Res., 26 (1998) 277.
Bourne, H.R. and Meng, E.C., Science, 289 (2000) 733.
Lopez-Rodriguez, M.L., Murcia, M., Benhamu, B., Viso, A., Campillo, M. and Pardo, L., Bioorg. Med. Chem. Lett., 11 (2001) 2807.
Lopez-Rodriguez, M.L., Murcia, M., Benhamu, B., Olivella, M., Campillo, M. and Pardo, L., J. Comput.-Aided Mol. Des., 15 (2001) 1025.
Lopez-Rodriguez, M.L., Murcia, M., Benhamu, B., Viso, A., Campillo, M. and Pardo, L., J. Med. Chem., 45 (2002) 4806.
Mialet, J., Dahmoune, Y., Lezoualc'h, F., Berque-Bestel, I., Eftekhari, P., Hoebeke, J., Sicsic, S., Langlois, M. and Fischmeister, R., Br. J. Pharmacol., 130 (2000) 527.
Ballesteros, J.A. and Weinstein, H., Meth. Neurosci., 25 (1995) 366.
Joubert, L., Claeysen, S., Sebben, M., Bessis, A.S., Clark, R.D., Martin, R.S., Bockaert, J. and Dumuis, A., J. Biol. Chem., 277 (2002) 25502.
Lopez-Rodriguez, M.L., Morcillo, M.J., Benhamu, B. and Rosado, M.L., J. Comput.-Aided Mol. Des., 11 (1997) 589.
Langlois, M. and Fischmeister, R., J. Med. Chem., 46 (2003) 319.
Ballesteros, J.A., Deupi, X., Olivella, M., Haaksma, E.E. and Pardo, L., Biophys. J., 79 (2000) 2754.
Lopez-Rodriguez, M.L., Vicente, B., Deupi, X., Barrondo, S., Olivella, M., Morcillo, M.J., Behamu, B., Ballesteros, J.A., Salles, J. and Pardo, L., Mol. Pharmacol., 62 (2002) 15.
Olivella, M., Deupi, X., Govaerts, C. and Pardo, L., Biophys. J., 82 (2002) 3207.
Frisch, M.J., Trucks, G.W., Schlegel, H.B., Scuseria, G.E., Robb, M.A. et al. (1998) GAUSSIAN-98.
Case, D.A., Pearlman, D.A., Caldwell, J.W., Cheatham III, T.E., Wang, J. et al. (2002) AMBER7, University of California, San Francisco, CA.
Cornell, W.D., Cieplak, P., Bayly, C.I., Gould, I.R., Merz Jr., K.M., Ferguson, D.M., Spellmeyer, D.C., Fox, T., Caldwell, J.W. and Kollman, P.A., J. Am. Chem. Soc., 117 (1995) 5179.
Cieplak, P., Cornell, W.D., Bayly, C. and Kollman, P.A., J. Comput. Chem., 16 (1995) 1357.
Lopez-Rodriguez, M.L., Benhamu, B., Viso, A., Morcillo, M.J., Murcia, M., Orensanz, L., Alfaro, M.J. and Martin, M.I., Bioorg. Med. Chem., 7 (1999) 2271.
Grossman, C.J., Kilpatrick, G.J. and Bunce, K.T., Br. J. Pharmacol., 109 (1993) 618.
Cheng, Y.C. and Prusoff, W.H., Biochem. Pharmacol., 22 (1973) 3099.
Lowry, O.H., Rosebrough, N.J., Farr, A.L. and Randall, R.J., J. Biol. Chem., 193 (1951) 265.
Farrens, D.L., Altenbach, C., Yang, K., Hubbell, W.L. and Khorana, H.G., Science, 274 (1996) 768.
Gether, U., Lin, S., Ghanouni, P., Ballesteros, J.A., Weinstein, H. and Kobilka, B.K., EMBO J., 16 (1997) 6737.
Sheikh, S.P., Zvyaga, T.A., Lichtarge, O., Sakmar, T.P. and Bourne, H.R., Nature, 383 (1996) 347.
Lopez-Rodriguez, M.L., Morcillo, M.J., Fernandez, E., Porras, E., Orensanz, L., Beneytez, M.E., Manzanares, J. and Fuentes, J.A., J. Med. Chem., 44 (2001) 186.
Lopez-Rodriguez, M.L., Morcillo, M.J., Fernandez, E., Rosado, M.L., Pardo, L. and Schaper, K., J. Med. Chem., 44 (2001) 198.
Lopez-Rodriguez, M.L., Benhamu, B., Morcillo, M.J., Murcia, M., Viso, A., Campillo, M. and Pardo, L., Curr. Top. Med. Chem., 2 (2002) 625.
Claeysen, S., Joubert, L., Sebben, M., Bockaert, J. and Dumuis, A., J. Biol. Chem., 278 (2003) 699.
Guo, W., Shi, L. and Javitch, J.A., J. Biol. Chem., 278 (2003) 4385.
Fotiadis, D., Liang, Y., Filipek, S., Saperstein, D.A., Engel, A. and Palczewski, K., Nature, 421 (2003) 127.
Kraulis, J., J. Appl. Cryst., 24 (1991) 946.
Merritt, E.A. and Bacon, D.J., Meth. Enzymol., 277 (1997) 505.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
López-Rodríguez, M.L., Benhamú, B., Murcia, M. et al. Benzimidazole derivatives. 4. The recognition of the voluminous substituent attached to the basic amino group of 5-HT4 receptor antagonists. J Comput Aided Mol Des 17, 515–524 (2003). https://doi.org/10.1023/B:JCAM.0000004601.34056.c1
Issue Date:
DOI: https://doi.org/10.1023/B:JCAM.0000004601.34056.c1